Market Research Logo

Global Biodefense Market 2017-2021

Global Biodefense Market 2017-2021

About Biodefense

Biodefense is the use of medical measures to protect people against bioterrorism. It mainly applies to two different target populations, namely military combatant (troops in the field) and civilian non-combatant. The protection of food supplies and water are often considered a critical part of biodefense. Owing to the increasing threat of terrorism and bioterrorism, the risk posed by exposure to biological agents that can be used as biological weapons must be evaluated. Biological agents used in warfare may prove to be more potent than conventional weapons. In the last century, the developments made in biochemistry and biotechnology have simplified the production of such weapons. Genetic engineering can be used to create new pathogens by manipulating genes, thereby giving rise to a whole new generation of genetically modified bioweapons. Factors such as ease of production, availability of technical know-how, and the extensive accessibility of biological agents have further led to the threat of biological weapons.

Technavio’s analysts forecast the global biodefense market to grow at a CAGR of 5.41% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global biodefense market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of biodefense.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Biodefense market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Altimmune
  • Bavarian Nordic
  • DynPort Vaccine Company (DVC)
  • Emergent BioSolutions
Other prominent vendors
  • Acambis
  • Achaogen
  • Cleveland BioLabs
  • Elusys Therapeutics
Market driver
  • Growing threat of bioterrorism
  • For a full, detailed list, view our report
Market challenge
  • Lack of information about bioengineered organisms attack
  • For a full, detailed list, view our report
Market trend
  • Government initiatives
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Biodefense market 2017-2021

Technavio recognizes the following companies as the key players in the global biodefense market: Altimmune, Bavarian Nordic, DynPort Vaccine Company (DVC), and Emergent BioSolutions

Other Prominent Vendors in the market are: Acambis, Achaogen, Cleveland BioLabs, and Elusys Therapeutics

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Government initiatives. Biological agents are easy to obtain as these are naturally present in the environment. The possibility of developing novel weapons through the use of these agents is alarming. Laboratories, across the world, are working on the development of advanced detection systems to identify areas and populations at risk of bioterrorism, provide early warning, and facilitate prompt treatment. Forensic technologies in many countries such as the US are working on identifying biological agents, their environmental origins, and their initial sources. Efforts include sanitization technologies to reinstate facilities without causing any additional concerns.”

According to the report, one of the major drivers for this market is Growing threat of bioterrorism. Bioterrorism is defined as a form of terrorism that involves the intentional release or distribution of harmful biological agents for mass destruction of life. These biological agents can be viruses, fungi, protozoa, or bacteria. They are ubiquitous in the natural environment, where they are found in soil, water, plants, and animals. However, they can be genetically modified in laboratories to enhance their lethal properties. Bioterrorism agents being relatively inexpensive and easy to obtain when compared with weapons and chemical agents, can be used for mass destruction. Further, since they can be easily disseminated, their use as bioterrorism agents is unconstrained. They adversely affect human health, ranging from mild allergic reactions to serious medical conditions that can be life-threatening.

Further, the report states that one of the major factors hindering the growth of this market is Lack of information about bioengineered organisms attack. Genetically altered organisms are widely used in the scientific study and have facilitated the development of new medical therapies, preventive strategies, and diagnostic tools. However, such organisms can be maliciously used such as their use in bioterrorism. Intentional or accidental transmission to humans can lead to adverse health effects. However, the unique microbial properties of genetically engineered organisms and the clinical symptoms shown by persons infected with them may obstruct the normal diagnostic, and clinical assessments or preventive approaches as the genetically modified strains are never field-tested. Hence, the actual virulence potential of these microbes remains unknown. Concerns about biotechnology being used to develop new pathogens with exclusive properties or to create completely new classes of biological threat agents is a huge challenge for the global biodefense market in the current scenario.

Companies Mentioned

Altimmune, Bavarian Nordic, DynPort Vaccine Company (DVC), Emergent BioSolutions, Acambis, Achaogen, Cleveland BioLabs, and Elusys Therapeutics

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
      • Table CDC classification of bioterrorism agents
  • Market landscape
    • Market overview
      • Table Global biodefense market: Snapshot
      • Table Global biodefense market 2016-2021 ($ millions)
      • Table Global biodefense market: Year-over-year (YoY) growth 2017-2021 (%)
      • Table Global biodefense market: Opportunity analysis
  • Five forces analysis
    • Table Five forces analysis
  • Market segmentation by application
    • Table Global biodefense market share by application 2016-2021 (%)
    • Comparison by application
      • Table Comparison by application
    • Global biodefense against anthrax market
      • Table Spread of anthrax
      • Table Types of anthrax
      • Table Global biodefense against anthrax market 2016-2021 ($ millions)
      • Table Global biodefense against anthrax market: YoY growth 2017-2021 (%)
      • Table Factors responsible for making anthrax a deadly bioweapon
      • Table Types of anthrax vaccine
    • Global biodefense against smallpox market
      • Table Global biodefense against smallpox market 2016-2021 ($ millions)
      • Table Global biodefense against smallpox market: YoY growth 2017-2021 (%)
    • Global biodefense against botulism market
      • Table Types of botulism
      • Table Global biodefense against botulism market 2016-2021 ($ millions)
      • Table Global biodefense against botulism market: YoY growth 2017-2021 (%)
    • Global biodefense against others market
      • Table Global biodefense against others market 2016-2021 ($ millions)
      • Table Global biodefense against others market: YoY growth 2017-2021 (%)
    • Market opportunity
  • Regional landscape
    • Table Global biodefense market share by region 2016-2021 (%)
    • Regional comparison
      • Table Regional comparison
    • Biodefense market in Americas
      • Table Biodefense market in Americas 2016-2021 ($ millions)
      • Table Biodefense market: YoY growth in Americas (%)
    • Biodefense market in EMEA
      • Table Biodefense market in EMEA 2016-2021 ($ millions)
      • Table Biodefense market: YoY growth in EMEA 2017-2021 (%)
    • Biodefense market in APAC
      • Table Biodefense market in APAC 2016-2021 ($ millions)
      • Table Biodefense market: YoY growth in APAC 2017-2021 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Recent outbreaks, 2017
    • Market challenges
  • Market trends
    • Government initiatives
    • Growing collaborations and M&A
  • Vendor landscape
    • Competitive landscape
      • Table Competitive structure analysis of global biodefense market
    • Altimmune
      • Table Altimmune: Key highlights
      • Table Altimmune: Strength assessment
      • Table Altimmune: Strategy assessment
      • Table Altimmune: Opportunity assessment
    • Bavarian Nordic
      • Table Bavarian Nordic: Key highlights
      • Table Bavarian Nordic: Strength assessment
      • Table Bavarian Nordic: Strategy assessment
      • Table Bavarian Nordic: Opportunity assessment
    • DynPort Vaccine Company (DVC)
      • Table DVC: Key highlights
      • Table DVC: Strength assessment
      • Table DVC: Strategy assessment
      • Table DVC: Opportunity assessment
    • Emergent BioSolutions
      • Table Emergent BioSolutions: Key highlights
      • Table Emergent BioSolutions: Strength assessment
      • Table Emergent BioSolutions: Strategy assessment
      • Table Emergent BioSolutions: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report